These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18418412)

  • 21. Intra- and interobserver variability of image-based PASI assessments in 120 patients suffering from plaque-type psoriasis.
    Fink C; Alt C; Uhlmann L; Klose C; Enk A; Haenssle HA
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1314-1319. PubMed ID: 29569769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Objective measurements of erythema, elasticity and scale could overcome the inter- and intra-observer variations of subjective evaluations for psoriasis severity.
    Choi JW; Kwon SH; Youn JI; Youn SW
    Eur J Dermatol; 2013 Apr; 23(2):224-9. PubMed ID: 23518409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings.
    Kwon HH; Kim MW; Park GH; Bae YI; Kuk SK; Suh DH; Youn JI; Kwon IH
    J Dermatol; 2016 Aug; 43(8):894-9. PubMed ID: 26992293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M; Mirada A; López S; Artés M;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
    Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of machine vision to assess involved surface in patients with psoriasis.
    Savolainen L; Kontinen J; Röning J; Oikarinen A
    Br J Dermatol; 1997 Sep; 137(3):395-400. PubMed ID: 9349336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.
    Balato N; Megna M; Di Costanzo L; Balato A; Ayala F
    Br J Dermatol; 2013 Jan; 168(1):201-5. PubMed ID: 23240729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a simple measure of psoriasis severity based on a longitudinal study of Chinese patients.
    Cao D; Shen M; Chen X; Xiao Y; Lu W; Luo Y; Zhu W; Kuang Y
    Eur J Dermatol; 2020 Dec; 30(6):674-679. PubMed ID: 33459259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical severity of psoriasis in last 20 years of PUVA study.
    Nijsten T; Looman CW; Stern RS
    Arch Dermatol; 2007 Sep; 143(9):1113-21. PubMed ID: 17875871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of a vasculitis activity index for systemic necrotizing vasculitis.
    Whiting-O'Keefe QE; Stone JH; Hellmann DB
    Arthritis Rheum; 1999 Nov; 42(11):2365-71. PubMed ID: 10555032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
    Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II clinical trial of bexarotene gel 1% in psoriasis.
    Breneman D; Sheth P; Berger V; Naini V; Stevens V
    J Drugs Dermatol; 2007 May; 6(5):501-6. PubMed ID: 17679184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, tolerability, and pharmacodynamics of apremilast in recalcitrant plaque psoriasis: a phase II open-label study.
    Gottlieb AB; Matheson RT; Menter A; Leonardi CL; Day RM; Hu C; Schafer PH; Krueger JG
    J Drugs Dermatol; 2013 Aug; 12(8):888-97. PubMed ID: 23986162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
    Gordon KB; Duffin KC; Bissonnette R; Prinz JC; Wasfi Y; Li S; Shen YK; Szapary P; Randazzo B; Reich K
    N Engl J Med; 2015 Jul; 373(2):136-44. PubMed ID: 26154787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The self-administered psoriasis area and severity index is valid and reliable.
    Feldman SR; Fleischer AB; Reboussin DM; Rapp SR; Exum ML; Clark AR; Nurre L
    J Invest Dermatol; 1996 Jan; 106(1):183-6. PubMed ID: 8592072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.
    Shikiar R; Bresnahan BW; Stone SP; Thompson C; Koo J; Revicki DA
    Health Qual Life Outcomes; 2003 Oct; 1():53. PubMed ID: 14613569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photographic assessment of burn size and depth: reliability and validity.
    Hop MJ; Moues CM; Bogomolova K; Nieuwenhuis MK; Oen IM; Middelkoop E; Breederveld RS; van Baar ME
    J Wound Care; 2014 Mar; 23(3):144-5, 148-52. PubMed ID: 24633060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mental health self-assessment in patients with moderate to severe psoriasis: an observational, multicenter study of 1164 patients in Spain (the VACAP Study).
    Pujol RM; Puig L; Daudén E; Sánchez-Carazo JL; Toribio J; Vanaclocha F; Yébenes M; Sabater E; Casado MA; Caloto MT; Aragón B
    Actas Dermosifiliogr; 2013 Dec; 104(10):897-903. PubMed ID: 24112536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability Between In-Person and Still Photograph Assessment of Facial Function in Facial Paralysis Using the eFACE Facial Grading System.
    Malka R; Miller M; Guarin D; Fullerton Z; Hadlock T; Banks C
    Facial Plast Surg Aesthet Med; 2021 Sep; 23(5):344-349. PubMed ID: 33325774
    [No Abstract]   [Full Text] [Related]  

  • 40. Observer-independent assessment of psoriasis-affected area using machine learning.
    Meienberger N; Anzengruber F; Amruthalingam L; Christen R; Koller T; Maul JT; Pouly M; Djamei V; Navarini AA
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1362-1368. PubMed ID: 31594034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.